Ads
related to: acute leukemia in adults- Safety
Learn More About Well Characterized
Safety Profile.
- Dosing & Monitoring
Twice Daily
Oral Dosing.
- Efficacy
Durable Complete Remissions
for R/R AML Patients.
- Access & Resources
Support is Available for
You and Your Patients.
- Safety
Search results
Autolus reports promising results for obe-cel in leukemia study By Investing.com
Investing.com· 21 hours agoAutolus Therapeutics plc (NASDAQ:AUTL), a biopharmaceutical company focused on T cell therapies for...
Novel CAR T therapy and shorter targeted therapy durations show promise for patients with leukemia
Medical Xpress· 20 hours ago(ASCO) Annual Meeting. The novel anti-CD19 autologous chimeric antigen receptor (CAR) T cell therapy...
Researchers discover that a type of childhood leukemia originates during fetal development
Medical Xpress· 2 days agoAcute myeloid leukemia is the second most common type of acute leukemia in childhood and can be...
Autolus shares hold steady with Buy rating on Obe-cel market penetration By Investing.com
Investing.com· 2 days agoOn Thursday, Truist Securities maintained a Buy rating on shares of Autolus Therapeutics Plc...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 22 hours agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...
Eldridge family establishes hospital fund to help other families of children with cancer
Quad-City Times· 2 days agoHudson McKearney is a 7-year-old boy who loves superheroes. Just before his second birthday,...
New Gene Tests Can Predict if a Drug Will Work for a Patient
Medscape· 1 day agoWhat if there were tests that could tell you whether the following drugs were a good match for your...
7 Biotech Stocks to Put on Your Breakthrough Radar
InvestorPlace· 5 days agoFor those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower....
Jasper Therapeutics to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI...
Benzinga· 2 days agoREDWOOD CITY, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (NASDAQ:JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting
Ads
related to: acute leukemia in adults